TCRR

TCR2 Therapeutics (TCRR)

TCR2 Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TCRR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/12	20:01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/06	19:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/06	19:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/06	19:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/06	05:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/06	05:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/06	05:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/06	05:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:46	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:44	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:42	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:41	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:40	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:39	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/02	05:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/06/01	22:35	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/31	05:22	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/31	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/25	05:57	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/25	05:53	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/25	05:53	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/25	05:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/25	05:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TCRR	TCR2 Therapeutics Inc
2023/05/22	20:34	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:TCRR	TCR2 Therapeutics Inc